ニュース

米FDA、新型コロナワクチン接種を65歳以上・高リスク者に限定へ
【ワシントンＡＦＰ＝時事】米食品医薬品局（ＦＤＡ）は２０日、新型コロナウイルスワクチンの追加接種を６５歳以上、または深刻な基礎疾患がある人に制限する方針を示した。６５歳未満で基礎疾患のない個人に関しては、ワクチンを製造する製薬会社に新たな臨床試験の実 ...
ブルームバーグ on MSN1 日
新型コロナ、追加接種ワクチン申請にFDAが新たな臨床試験義務付け
健康な成人と子どもを対象とした新型コロナウイルス感染症のブースター接種について、米規制当局は今後、新たな臨床試験で安全性と有効性が確認されることを承認の条件とする。コストのかかる新要件が追加され、将来的にはワクチン接種対象者が絞られる可能性もある。
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
FDA plans to limit COVID shots to those over 65 or with high-risk conditions
Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC has historically set vaccine recommendations, while the FDA determines which ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Public Broadcasting Service (PBS)11 時間
Who is eligible for a COVID shot? What to know about the FDA’s latest changes
The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...
FDA announces plans to restrict access for COVID vaccines
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
FDA to limit covid shot approval to 65+, those with medical conditions
The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
The FDA is making it more difficult for Americans to get vaccinated for covid
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...